The effects of intravenous practolol 0.4 mg/kg were studied in 12 hypertensive patients during halothane/nitrous oxide anaesthesia. Practolol decreased heart rate (HR) and cardiac output (Q) from the elevated levels following atropine administration during anaesthesia, but values of arterial pressure (AP), HR and Q after the combination of atropine and practolol were not significantly different from those during anaesthesia prior to blockade. The effects of a similar anaesthetic sequence were studied in a further 11 treated hypertensive patients given practolol by mouth 1.5 mg/kg/6 hours for at least 48 hours preoperatively in addition to current anti-hypertensive therapy. By comparison with treated hypertensive patients previously studied, those pretreated with practolol had similar AP awake, but higher AP throughout anaesthesia with either spontaneous or artificial ventilation. Cardiac output was higher and systemic vascular resistance was lower both before and during anaesthesia. Both the present groups of patients showed significantly attenuated responses of tachycardia and hypertension following laryngoscopy and intubation compared with previous studies. The incidence of dysrhythmia and e.c.g. evidence of myocardial ischaemia was significantly lower (4%) in beta-blocked patients compared with those who had not received practolol (38%).
In a previous publication, we described the occurrence and consequences in hypertensive patients of exaggerated responses of tachycardia with dysrhythmia and hypertension following laryngoscopy and endotracheal intubation (Prys-Roberts et al., 1971b) . We implied that these responses represented an exaggeration of the response shown by normotensive subjects, and since this type of response has been shown to be mediated in experimental animals through the sympathetic nervous system (Tomori and Widdicombe, 1969) , one rational approach was to attempt to suppress these responses with adrenergic beta-receptor blockade. The first part of this paper describes the haemodynamic responses of 12 hypertensive patients to beta-receptor blockade with practolol during established anaesthesia, and the subsequent modification of their responses to laryngoscopy and endotracheal intubation.
Beta-receptor blocking drugs are now increasingly used in the treatment of hypertension (Gillam and Prichard, 1964; Lydtin et al., 1972) , cardiac dysrhythmia (Harris, 1966; Schamroth, 1966) , ischaemic heart disease presenting with angina pectoris (MacAlpin, Kattus and Winfield, 1965; Bjorntorp, 1967) , hypertrophic obstructive cardiomyopathy (Cherian et al., 1966) , thyrotoxic tachycardia (Turner and Hill, 1968) and phaeochromocytoma (Blasi, 1964; Prichard and Ross, 1966) . Some of these patients may be treated with very large doses of beta-receptor blockers, and inevitably some present for either elective or emergency surgery. Despite the growing experience gained from the deliberate use of betareceptor blockers during anaesthesia (Payne and Senfield, 1964; Johnstone, 1966 Johnstone, ,1969 Jenkins, 1970; Stephen, Davie and Scott, 1971) , there has been a considerable reluctance on the part of anaesthetists to accept for surgery patients who are receiving beta-receptor blockers. At the 1972 Annual Meeting of the American Society of Anesthesiologists, a symposium was held on the subject of anaesthesia and coronary artery disease. The consensus of opinion among the panellists, comprising anaesthetists, surgeons and cardiologists, was that patients receiving •Present address: Department of Physiology, University of Ottawa, Ottawa, Ontario, Canada.
A preliminary communication of part of these studies was presented at the 1972 Annual Meeting of the American Society of Anesthesiolgists, Boston, Mass., and published in abstract at that meeting. beta-receptor blockers for the treatment of severe angina pectoris should have their therapy withdrawn prior to elective surgery. Another group of discussants (Ayscue et al., 1972) came to similar conclusions, though neither group provided anything more than anecdotal support for their arguments. Their two main concerns were that patients receiving betareceptor blockers tolerated anaesthesia poorly, and that impairment of the chronotropic and inotropic responses to stresses such as haemorrhage during anaesthesia was an unacceptable risk. Since the findings of the first study described in this paper indicated that beta-receptor blockade was well tolerated by hypertensive patients, and provided a beneficial therapeutic effect, it was decided that a further study of hypertensive patients who had been deliberately pretreated with generous doses of betareceptor blocking agents was justified This decision was fully supported by the physicians and cardiologists whose patients we studied.
METHODS
Two groups of hypertensive patients were studied, whose anthropometric and medical details are summarized in tables la and Ib. The patients were carefully examined by one of us prior to the study, TABLB I. Anthropometric and medical details of patients studied in Groups I and II. No. Sex and each patient gave his or her consent to the studies after a full explanation of the purposes of the study, and the relative benefits to themselves and others of the proposed therapy. Two discrete and separate studies were carried out, involving different investigational protocols.
First investigation: Group I.
Twelve hypertensive patients were brought to the anaesthetic room in their beds. Those (10) who were receiving antihypertensive therapy were maintained on their standard regime up to and including the morning of the study, and none were premedicated. Under local analgesia, an 18-gauge teflon cannula was percutaneously inserted into a brachial artery, and a similar but larger cannula (15-gauge) was inserted into contralateral antecubital vein. Through the latter a nylon catheter was floated into the central circulation, its final position being assessed according to die pressures recorded from the catheter. The standard 12-lead electrocardiogram was recorded from conventional limb and chest lead configurations, and heart rate was obtained from the e.c.g. signal by a Neilson instantaneous tachometer. Following the cannulations, the patients were allowed to rest undisturbed for 10-15 min in a level supine position before control measurements were obtained. Measurements of cardiac output by the dye dilution method were related to estimates of pulmonary gas exchange as obtained by Riley-Cournand analysis.
Anaesthesia was induced with either thiopentone 3 mg/kg or Althesin 0.05 ml/kg and subsequently maintained with 0.5% halothane vaporized in 70% nitrous oxide in oxygen, breathed through a Magill attachment and facemask. When a steady-state of anaesthesia had been attained (5-10 min), a further set of cardiovascular measurements was made and arterial and mixed venous samples were withdrawn. Atropine 0.02 mg/kg was administered intravenously and when heart rate had become steady after the initial rise, a further set of measurements was made.
Practolol 0.4 mg/kg was then administered intravenously in 4 divided doses given at 1-minute intervals, and a further set of measurements was made within 3-4 min. Immediately after these measurements, suxamethonium 75-100 mg was administered and laryngoscopy and endotracheal intubation was performed. The electrocardiogram (lead II), heart rate, arterial and right atrial pressures were continuously recorded throughout the duration of these manoeuvres. With the exception of die administration of atropine followed by practolol, the protocol was identical with that followed in our previous study (Prys-Roberts et al., 1971b) . A final set of measurements was made when spontaneous ventilation was re-established.
Second investigation: Group II.
Eleven patients were studied, all of whom were receiving anti-hypertensive therapy up to and including the morning of operation. Three of them had been receiving beta-adrenergic blockers for some time: two were receiving practolol by mouth (100 mg 6-hourly) together with phenoxybenzamine for the stabilization of hypertension caused by phaeochromocytoma. The third patient was already receiving propranolol as part of the treatment of essential hypertension. All other patients were given oral practolol 6 mg/kg/day divided into 6-hourly doses in addition to their pre-existing anti-hypertensive therapy. In two patients whose arterial pressures were markedly raised despite large doses of anti-hypertensive drugs, addition of oral practolol to their therapy brought their arterial pressures down to reasonable levels without causing postural hypotension or other undesirable symptoms. None of these patients were premedicated. The initial cannulations and other preparations were the same as for Group I. After the control cardiovascular measurements and RileyCournand analyses, atropine 0.02 mg/kg was administered intravenously to the conscious patient, and when heart rate had become steady, a further set of cardiovascular measurements was obtained. Anaesthesia was then induced with thiopentone 3 mg/kg or Althesin 0.05 ml/kg (Prys-Roberts, Foex and Biro, 1972a) and subsequently maintained with 0.5% halothane in nitrous oxide and oxygen. The subsequent protocol for administration of suxamethonium, laryngoscopy and intubation and the appropriate measurements followed that used in our previous study (Prys-Roberts et al., 1971b) . The details of the measurements and statistical treatment of the results have been described in previous papers in this series.
RESULTS

Group I.
Mean values of circulatory variables measured during the four main stages are shown in table II and figure 1. The mean values in the awake patients were similar to those recorded in our previous studies of hypertensive patients, as were those measured during steady-state anaesthesia prior to laryngoscopy and endotracheal intubation (Prys-Roberts et al., 1971a) . During steady-state anaesthesia, arterial pressures and cardiac output were significantly reduced compared with awake state, and arterial Pco, was significantly elevated (P<0.001) from 38.7 mm Hg (SD 7.3) to 50.8 mm Hg (SD 12.1).
Following injection of atropine, cardiac output rose significantly to levels which were slightly higher than awake values, the rise being associated with a significant increase in heart rate, but a fall in stroke volume. Systemic vascular resistance (SVR) fell consistently following atropine administration, reaching levels which were significantly lower than in the conscious patients.
Practolol caused significant reductions of heart rate and cardiac output from the values measured after atropine administration. However, the mean values of cardiac output, heart rate, stroke volume and arterial pressures after the combination of atropine and practolol were almost identical with those established during steady-state anaesthesia, though systemic vascular resistance was lower in most patients.
Group II.
The values of circulatory variables during the four stages of the study are shown in table IU. The mean values of cardiac output and stroke volume (both normalized for weight) were significantly higher (P<0.01) when compared with the awake values in Group I, and awake values in other conscious hypertensive patients (Prys-Roberts, Meloche and Foex, 1971) . Heart rate and arterial pressures were similar to those in the other groups, thus systemic vascular resistance was generally lower in the patients treated with practolol in addition to their current anti-hypertensive therapy. Administration of atropine to the conscious beta-blocked patients caused significant increases in heart rate and cardiac output, significant reductions in stroke volume and SVR, but no significant change in arterial pressures. During induction of anaesthesia with either thiopentone or Althesin, arterial pressure fell in every patient, but to a much lesser extent than in any of the previous groups we have studied. When a steady-state of anaesthesia with spontaneous ventilation was established, arterial pressures, cardiac output, stroke volume and SVR were significantly lower than in the awake patients despite higher heart rates. Nevertheless, arterial pressures and cardiac output were higher than during the comparable stage in Group I, though the differences were not significant. Following the intubation sequence described in the following section, measurements were made during artificial ventilation (mean Paco 2 25.2 mm Hg, SD 3.4) in eight patients. Cardiac output and stroke volume were significantly reduced by comparison with all the previous stages in this group, but were higher than the values measured under comparable conditions in our previous study (PrysRoberts et al., 1972c) . Although SVR was increased by comparison with the spontaneous ventilation stage, the increase in SVR was much smaller than that observed in hypertensive patients who had not been beta-blocked.
Responses to laryngoscopy and intubation.
The mean values of heart rate and arterial pressures in both Groups I and II are shown in table IV and figure 2, where they are compared with the appropriate values in a group of 30 patients who were not beta-blocked (Group EQ). In both groups in the present study, administration of 8uxamethonium had no significant effects on the circulation, although a fall of arterial pressure of more than 15 mm Hg occurred in two patients in Group TJ. Following laryngoscopy and intubation, heart rate increased only slightly in both groups, compared with a mean increase of more than 20/min in Group HI. Systolic arterial pressure increased by an average of 24 mm Hg (P<0.01) in Group I, but only 14 mm Hg (n.s.) in Group JJ, whereas there was an average increase of 60 mm Hg (P<0.001) in Group m. No dysrhythmia was observed in any of the beta-blocked patients in either Group I or II, nor was there any myocardial ischaemia as evidenced by ST segment changes or T wave inversion. This contrasted sharply and significantly (x'=7.4, P<0.001) with the 38% incidence of dysrhythmia and associated ischaemic e.c.g. changes following laryngoscopy and intubation in Group ELI (Prys-Roberts et al., 1971b) .
DISCUSSION
Since the discovery by Powell and Slater (1958) and Moran and Perkins (1958) that the dichloro-analogue of isoprenaline could competitively inhibit the effects of isoprenaline, adrenaline and noradrenaline on the heart, a number of adrenergic beta-receptor blocking agents have been synthesized and subjected to Hinimi evaluation. Although the therapeutic value of these drugs is now widely established, the attitudes of anaesthetists to their use during anaesthesia have been ambivalent, ranging from enthusiasm to frank antagonism. This dichotomy has more recently extended to the anaesthetic management of patients receiving beta-receptor blocking drugs for the treatment of hypertension or ischaemic heart disease. Like the previous controversy concerning antihypertensive therapy, the evidence, such as it is, for withholding beta-receptor blockade prior to elective anaesthesia is sparse and largely anecdotal. On the other hand, most cardiologists are reluctant to withdraw a form of therapy on which their patients are highly dependent, the consequences of which may lead to increased angina, decreased exercise tolerance and even death of the patient. Thus the anaesthetist must have powerful and convincing reasons for recommending the withdrawal of these drugs, amounting to evidence that patients receiving beta-receptor blockers are significantly more at risk during anaesthesia and surgery than if these agents are withdrawn. The present studies provide no such evidence, rather they provide evidence that hypertensive patients are protected from the undesirable sequelae of laryngoscopy and intubation, and from myocardial ischaemia associated with arterial hypotension during artificial ventilation.
To what extent the present findings are solely attributable to the effects of the beta-receptor blocker used in our studies is not dear, since the simultaneous use of large doses of atropine to prevent bradycardia may have confused the issue. While the use of atropine no doubt contributed to the higher levels of heart rate, cardiac output and arterial pressure during both the spontaneous and artificial ventilation stages of the patients in Group Et, it is unlikely to have had any significant effect in relation to the responses of laryngoscopy and intubation. The concept of anaesthetizing a patient whose heart is pharmacologically isolated from autonomic control by sympathetic and parasympathetic influences may be anathema to many, but there is no doubt that our patients tolerated both anaesthesia and surgery at least as well as patients who were not autonomically blocked. One view we hold strongly: beta-receptor blockers should not be administered during anaesthesia without a generous dose of atropine, unless there is clear evidence of excessive sympathetic activity, characterized by heart rates in excess of the human intrinsic rate of 92/min at a mean age of 45 (Jose, 1966) .
In the introduction of this paper we referred to commonly held and voiced reasons for withholding beta-receptor blockers prior to anaesthesia. Perhaps the commonest is that beta-blockade may impair cardiac performance, and a number of mechanisms have been implied (Strong et al., 1971 (Strong et al., , 1972 Ayscue et aL, 1972) . We have already disputed the evidence provided by Strong and his colleagues (Prys-Roberts and Foex, 1973) , and in separate publications (Foex, 1973; Foex and Prys-Roberts, 1973) we have produced evidence that during anaesthesia with either halothane, nitrous oxide, or a combination of both in dogs, propranolol did not directly decrease either myocardial contractility or ventricular performance. We further showed that, in doses which caused a tenfold shift to the right of the dose-response curve to infusions of isoprenaline, propranolol 0.3 mg/kg did not impair cardiac performance during normocapnic or hypocapnic artificial ventilation. Although we have not had the opportunity to study the effects of propranolol in the hypertensive patients, the results of the present study convince us that betareceptor blockade induced with practolol was not associated with impairment of cardiac performance so long as bradycardia due to parasympathetic stimulation of the heart was avoided.
It is therefore pertinent to ask why this concept of cardiac impairment by beta-receptor blockers should have arisen. One of us (C. P.-R.) has frequently heard the opinion voiced by anaesthetists on both sides of the Atlantic that beta-receptor blockers cause "myocardial depression by a quinidine-like effect" (sic), and that such myocardial depression is enhanced by or during anaesthesia. Beta-receptor blocking agents have complex pharmacological actions in addition to their competitive inhibitory action at adrenergic beta-receptors (Fitzgerald, 1969; Vaughan Williams, 1966 . Let us first compare the actions of quinidine on cardiac muscle, with those of beta-receptor blockers. Quinidine decreases the maTi'mnm rate of depolarization (MRD) of the myocardial cell, and increases the effective refractory period and thus decreases the excitability of the myocardium (Vaughan Williams, 1958) . In these respects, its actions are similar to those of the local anaesthetics procaine and lignocaine, and other drugs such as diphenylhydantoin. The concentration of these drugs required to decrease MRD is much lower than that required to block neuronal transmission by stabilization of the nerve membrane. Because beta-receptor blockers such as pronethalol and propranolol also stabilize cell membranes and act as local anaesthetics, their actions have been likened to those of quinidine. However, the membrane stabilization produced by beta-receptor blockers, unlike those of quinidine, cannot be modified by acetylcholine or changes in potassium concentration (Levy and Richards, 1965) . Furthermore, the laevo-isomer of propranolol has the same local anaesthetic potency and membrane-stabilizing activity as the dextro-isomer; while the beta-receptor blocking activity of the laevo-isomer is about 100 times greater (Barrett and Cullum, 1968) . Thus the evidence suggests that although some beta-receptor blockers do have membrane-stabilizing properties, these differ from those of quinidine, and are only evident at much higher dose levels than those required to produce effective beta-receptor blockade (Fitzgerald, 1969) . We must therefore consider other mechanisms by which beta-receptor blockers might impair cardiac function.
The contractile state of the myocardium in conscious man is a function of the inherent contractile state of the muscle and a variable degree of augmentation due to sympathetic nervous activity ( fig. 3, A) . If there is no sympathetic activity, as in the denervated heart, an intrinsic state of myocardial contractility is revealed ( fig. 3, B) . Most anaesthetic agents, like halothane, impair this contractile state of the denervated or isolated heart (Prys-Roberts et aL, 1972d), and are thus classified as direct myocardial depressants ( fig. 3, C) . In doses which cause effective beta-receptor blockade (0.2 mg/kg i.v.), propranolol may impair the contractile state of the heart when the comparison is made with the enhanced state of the innervated heart ( fig. 3, B) , but the final contractile state is no more depressed than that of the denervated heart. Higher doses of propranolol (2-3 mg/kg) may cause membrane stabilization and this will be associated with direct depression of the contractile state (Fitzgerald, 1969) .
When beta-receptor blocking doses of propranolol are administered during anaesthesia, the effect on the contractile state of the myocardium is dependent on the degree of sympathetic activity present. Thus during anaesthesia with halothane ( fig. 3, D) betareceptor blockade produces no further decrease in the contractile state, whereas during anaesthesia with either cycloproprane or diethyl ether ( fig. 3 , E and F), beta-receptor blockade decreases contractility in relation to the degree of sympathetic activity associated with these agents. In common with the prototype of the series dichloro-isoprenaline, many but not all beta-receptor blockers also have intrinsic sympathetic agonist activity (fig. 3, G and H) in that they cause tachycardia, a fall in blood pressure and an increase in blood sugar in catecholamine-depleted animals (Mayer, Moran and Fain, 1961; Fitzgerald, Wale and Austin, 1972) . Practolol has moderate intrinsic stimulating activity, but even in enormous doses it has no membrane-stabilizing properties, and has the advantage over many other beta-receptor blockers in being cardiospecific (Parratt and Wadsworth, 1969; Ross and Jorgensen, 1970 ). Practolol does not block i fl L, receptors in systemic blood vessels (Lands et al., 1967) , thus the vasodilator effects of beta-stimulating agents are preserved. This contrasts with propranolol which is predominantly specific to peripheral rather than cardiac beta-receptors (Vaughan Williams, 1972) and tends to cause arteriolar constriction and an increase in systemic vascular resistance (Brick et al., 1966) . For these reasons, practolol appeared to us the preferred agent for use in hypertensive patients, and our findings of higher cardiac output and stroke volume and reduced SVR in the patients in Group II would be in accord with the foregoing argument. While we could argue that these are desirable effects in the sense that they do not suggest any impairment of cardiac function in conscious subjects, we would prefer to draw the conclusion that no patient studied by us showed evidence of impaired cardiovascular performance during anaesthesia associated with beta-adrenergic receptor blockade. Thus we may return unhampered by such considerations to the question of benefits derived from beta-receptor blockade in hypertensive patients, and those with ischaemic heart disease.
We find it difficult to present a convincing case for the routine administration of beta-receptor blockers to hypertensive patients undergoing anaesthesia, largely because of the low incidence of permanent sequelae in the 65 patients whom we studied before the present series. Of these, only one patient had electrocardiographic evidence of myocardial ischaemia which persisted into the postoperative period. Nevertheless, the high rate (38%) of occurrence of such changes during anaesthesia, especially related to episodes of hypotension, or to left ventricular stress, did not induce in us a sense of complacency. Since the incidence of ischaemic changes in the patients treated with beta-receptor blockers was so low, we feel that further studies of their use are more than justified. In this context, it would appear that oral medication preoperatively is more effective than a single intravenous dose given immediately before the intubation sequence. We would further suggest that beta-receptor blockers are more effective drugs for the preoperative alleviation of the stress and the cardiovascular consequences induced by fear (Taggart and Carruthers, 1972) than the wide variety of opiates, hypnotics and tranquillizers in present-day use.
The improved efficacy of oral administration of practolol may be explained on the basis that the blood level of this drug rapidly reaches a peak after a single intravenous administration, and thereafter decays rapidly according to a three-component exponential (Aellig, Prichard and Scales, 1970; Scales and Cosgrove, 1970) , the initial half-life being approximately 5 min. The same effective blood concentration can be achieved and maintained for a longer time by giving a larger dose by the oral route.
One further important question has not been answered by this study, but is of prime interest to both anaesthetist and surgeon. How will the patient whose heart is effectively beta-receptor blocked respond to major haemorrhage during or after anaesthesia and surgery? The increase in heart rate which is part of the normal response to haemorrhage, and a useful warning, may be completely obtunded by beta-receptor blockade. We do not believe that this question can be satisfactorily answered from the results of human studies, since under clinical conditions, haemorrhage is not easily quantifiable and is unlikely to occur in a sufficiently controlled manner as to allow comparable measurements in different patients. What evidence there is from animal studies suggests that beta-receptor blockade exerts a protective influence against haemorrhagic shock in sheep and dogs (Halmagyi, 1972; Halmagyi, Irving and Varga, 1968; Berk et al., 1967) , and in man (Berk et al., 1972 Los efectos del practolol intravenoso (0,4 mg/kg) fueron estudiados en doce pacientes hipertensos durante la anestesia de halothane/6xido nitroso. El practolol disminuy6 la frecuencia cardiaca (RQ y el gasto cardiaco (Q), cuando se parria de los grandes valores que seguian a la administration de atropina durante la anestesia, pcro los valores de la presion anerial (PA), RC y 0 despues de la combinaci6n de atropina y practolol no fueron significativamente diferentes que los obtenidos durante la anestesia antes del bloqueo. Los efectos consecutivos a una anestesia similar fueron estudiados en otros once pacientes hipertensos a los que sc administro practolol por via oral (1,5 mg/kg/6 horas), por lo menos 48 horas antes de la operation y juntamente con un tratamiento hipertensivo normal. Comparandolos con los enfermos hipertensos antcriormente estudiados, los tratados con practolol tenian una PA similar al despertar, pero 4sta era superior durante la anestesia con respiration espontanea o artificial. El gasto cardiaco era superior y la resistenda vascular sistemica inferior antes y durante la anestesia. Los dos grupos de pacientes presentados mostraron respuestas significativamente mis atenuadas de taquicardia e hipertensi6n despues de la laringoscopia e intubaci6n, comparados con los estudios previos. La intidencia de disritmia y evidencia electrocardiografica de isquemia miocardica era apreciablemente inferior (4%) en los pacientes beta-bloqueados, comparados con los que no habian recibido practolol (38%). Price £5. In their introduction the editors have wisely decided to avoid discussion of anaesthetic technique and to confine themselves to those factors within the anaesthetist's sphere of surveillance which determine success or failure in patients having major cancer surgery. Therefore, they deal with such things as the duration of surgery, the problems of blood transfusion, the interpretation of central venous pressure measurements, shock, lacticatidaemia, and coagulation defects. The authors with one exception are attached to Cornell University Medical College, and are also anaesthetists at various hospitals in New York. In the main they base their views on actual experience and are able to give supporting data from their own practice. Naturally those chapters where this is done stand out from the rest, and contain the most interesting matter for the reader.
BOOK REVIEW
They observe how prolonged surgery produces bizarre changes of temperature. Their re-evaluation of massive blood transfusion exposes not only the hazard of microemboli but that warming the blood and the administration of sodium bicarbonate lowers the operative mortality rate. They conclude that the practice of giving calcium salts to prevent "citric intoxication" cannot be validated and should probably be abandoned. They confirm once again that central venous pressure measurement provides valuable information, so long as the anaesthetist is aware of its limitations.
In a final chapter on "Clinical applications" valuable examples are given of the beneficial effects of applying the lessons leamt in the main body of the book. This is an excellent number of the Clinical Anesthesia Series, and is well worth reading. Incidentally, it provides the perfect answer to any accusation that the anaesthetist is a technician, or that anaesthesia does not demand the highest intellectual efforts.
William W. Mushm
